• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Andrew H. Beck, MD PhD


  • Lochhead P, Chan AT, Nishihara R, Fuchs CS, Beck AH, Giovannucci E, Ogino S.Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression.Mod Pathol. 2014 Jun 13.
  • Hefti MM, Hu R, Knoblauch NW, Collins LC, Haibe-Kains B, Tamimi RM, Beck AH.Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype.Breast Cancer Res. 2013;15(4):R68.
  • Grabiner BC, Nardi V, Birsoy K, Possemato R, Shen K, Sinha S, Jordan A, Beck AH, Sabatini DM.A Diverse Array of Cancer-Associated MTOR Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity.Cancer Discovery. 2014 Apr 17.
  • Elloul S, Kedrin D, Knoblauch NW, Beck AH, Toker A.The adherens junction protein afadin is an AKT substrate that regulates breast cancer cell migration.Mol Cancer Res. 2014 Mar;12(3):464-76.
  • Bateman AR, El-Hachem N, Beck AH, Aerts HJ, Haibe-Kains B.Importance of collection in gene set enrichment analysis of drug response in cancer cell lines.Sci Rep. 2014;4:4092.
  • Chin YR, Yoshida T, Marusyk A, Beck AH, Polyak K, Toker A.Targeting Akt3 signaling in triple-negative breast cancer.Cancer Res. 2014 Feb 1;74(3):964-73.
  • Bertrand KA, Tamimi RM, Scott CG, Jensen MR, Pankratz VS, Visscher D, Norman A, Couch F, Shepherd J, Fan B, Chen YY, Ma L, Beck AH, Cummings SR, Kerlikowske K, Vachon CM.Mammographic density and risk of breast cancer by age and tumor characteristics.Breast Cancer Res. 2013 Nov 4;15(6):R104.
  • Haibe-Kains B, El-Hachem N, Birkbak NJ, Jin AC, Beck AH, Aerts HJ, Quackenbush J.Inconsistency in large pharmacogenomic studies.Nature. 2013 Dec 19;504(7480):389-93.
  • van de Rijn M, Guo X, Sweeney RT, Beck AH, West RB.Molecular pathological analysis of sarcomas using paraffin-embedded tissue: current limitations and future possibilities.Histopathology. 2014 Jan;64(1):163-70.
  • Reschke M, Clohessy JG, Seitzer N, Goldstein DP, Breitkopf SB, Schmolze DB, Ala U, Asara JM, Beck AH, Pandolfi PP.Characterization and analysis of the composition and dynamics of the mammalian riboproteome.Cell Rep. 2013 Sep 26;4(6):1276-87.
  • Jeselsohn RM, Werner L, Regan MM, Fatima A, Gilmore L, Collins LC, Beck AH, Bailey ST, He HH, Buchwalter G, Brown M, Iglehart JD, Richardson A, Come SE.Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune response.PLoS ONE. 2013;8(5):e64225.
  • Bala R, Pinsky BA, Beck AH, Kong CS, Welton ML, Longacre TA.p16 Is Superior to ProEx C in Identifying High-grade Squamous Intraepithelial Lesions (HSIL) of the Anal Canal.Am J Surg Pathol. 2013 May;37(5):659-68.
  • Beck AH, Knoblauch NW, Hefti MM, Kaplan J, Schnitt SJ, Culhane AC, Schroeder MS, Risch T, Quackenbush J, Haibe-Kains B.Significance analysis of prognostic signatures.PLoS Comput. Biol. 2013 Jan;9(1):e1002875.
  • Ogino S, King EE, Beck AH, Sherman ME, Milner DA, Giovannucci E.Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science.Am J Epidemiol. 2012 Oct 15;176(8):659-67.
  • Ogino S, Beck AH, King EE, Sherman ME, Milner DA, Giovannucci E.Ogino et Al. Respond to "the 21st century epidemiologist".Am J Epidemiol. 2012 Oct 15;176(8):672-4.
  • Brunner AL, Beck AH, Edris B, Sweeney RT, Zhu SX, Li R, Montgomery K, Varma S, Gilks T, Guo X, Foley JW, Witten DM, Giacomini CP, Flynn RA, Pollack JR, Tibshirani R, Chang HY, van de Rijn M, West RB.Transcriptional profiling of lncRNAs and novel transcribed regions across a diverse panel of archived human cancers.Genome Biol. 2012 Aug 28;13(8):R75.
  • Edris B, Fletcher JA, West RB, van de Rijn M, Beck AH.Comparative gene expression profiling of benign and malignant lesions reveals candidate therapeutic compounds for leiomyosarcoma.Sarcoma. 2012;2012:805614.
  • Mills AM, Beck AH, Pourmand N, Le QT, Kong CS.Evaluation of ProExC as a prognostic marker in oropharyngeal squamous cell carcinomas.Am J Surg Pathol. 2012 Aug;36(8):1158-64.
  • Beck AH, Sangoi AR, Leung S, Marinelli RJ, Nielsen TO, van de Vijver MJ, West RB, van de Rijn M, Koller D.Systematic analysis of breast cancer morphology uncovers stromal features associated with survival.Sci Transl Med. 2011 Nov 9;3(108):108ra113.
  • Espinosa I, Edris B, Lee CH, Cheng HW, Gilks CB, Wang Y, Montgomery KD, Varma S, Li R, Marinelli RJ, West RB, Nielsen T, Beck AH, van de Rijn M.CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis.Am J Pathol. 2011 Oct;179(4):2100-7.
  • Wu K, Liu JJ, Adams W, Sonn GA, Mach KE, Pan Y, Beck AH, Jensen KC, Liao JC.Dynamic Real-time Microscopy of the Urinary Tract Using Confocal Laser Endomicroscopy.Urology. 2011 Jul;78(1):225-31.
  • Beck AH, Rodriguez-Paris J, Zehnder J, Schrijver I.Evaluation of a gene expression microarray-based assay to determine tissue type of origin on a diverse set of 49 malignancies.Am J Surg Pathol. 2011 Jul;35(7):1030-7.
  • Younes SF, Beck AH, Ohgami RS, Lossos IS, Levy R, Warnke RA, Natkunam Y.The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow.Am J Clin Pathol. 2011 May;135(5):697-708.
  • Mills AM, Beck AH, Montgomery KD, Zhu SX, Espinosa I, Lee CH, Subramanian S, Fletcher CD, van de Rijn M, West RB.Expression of subtype-specific group 1 leiomyosarcoma markers in a wide variety of sarcomas by gene expression analysis and immunohistochemistry.Am J Surg Pathol. 2011 Apr;35(4):583-9.
  • Sangoi AR, Ohgami RS, Pai RK, Beck AH, McKenney JK, Pai RK.PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.Mod Pathol. 2011 Mar;24(3):412-24.
  • Wu JM, Beck AH, Pate LL, Witten D, Zhu SX, Montgomery KD, Allison KH, van de Rijn M, West RB.Endogenous versus tumor-specific host response to breast carcinoma: a study of stromal response in synchronous breast primaries and biopsy site changes.Clin Cancer Res. 2011 Feb 1;17(3):437-46.
  • Pai RK, Beck AH, Mitchem J, Linehan DC, Chang DT, Norton JA, Pai RK.Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.Am J Surg Pathol. 2011 Feb;35(2):228-34.
  • Webster JA, Beck AH, Sharma M, Espinosa I, Weigelt B, Schreuder M, Montgomery KD, Jensen KC, van de Rijn M, West R.Variations in stromal signatures in breast and colorectal cancer metastases.J Pathol. 2010 Oct;222(2):158-65.
  • Younes SF, Beck AH, Lossos IS, Levy R, Warnke RA, Natkunam Y.Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components.Am J Surg Pathol. 2010 Sep;34(9):1266-76.
  • Sangoi AR, Beck AH, Amin MB, Cheng L, Epstein JI, Hansel DE, Iczkowski KA, Lopez-Beltran A, Oliva E, Paner GP, Reuter VE, Ro JY, Shah RB, Shen SS, Tamboli P, McKenney JK.Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists.Am J Surg Pathol. 2010 Sep;34(9):1367-76.
  • Sharma M, Beck AH, Webster JA, Espinosa I, Montgomery K, Varma S, van de Rijn M, Jensen KC, West RB.Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.Breast Cancer Res Treat. 2010 Sep;123(2):397-404.
  • Kong CS, Beck AH, Longacre TA.A panel of 3 markers including p16, ProExC, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas.Am J Surg Pathol. 2010 Jul;34(7):915-26.
  • Zhang B, Beck AH, Taube JM, Kohler S, Seo K, Zwerner J, Viakhereva N, Sundram U, Kim YH, Schrijver I, Arber DA, Zehnder JL.Combined use of PCR-based TCRG and TCRB clonality tests on paraffin-embedded skin tissue in the differential diagnosis of mycosis fungoides and inflammatory dermatoses.J Mol Diagn. 2010 May;12(3):320-7.
  • Beck AH, West RB, van de Rijn M.Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers.Virchows Arch. 2010 Feb;456(2):141-51. Review.
  • Beck AH, Lee CH, Witten DM, Gleason BC, Edris B, Espinosa I, Zhu S, Li R, Montgomery KD, Marinelli RJ, Tibshirani R, Hastie T, Jablons DM, Rubin BP, Fletcher CD, West RB, van de Rijn M.Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling.Oncogene. 2010 Feb 11;29(6):845-54.
  • Pai RK, Beck AH, Norton JA, Longacre TA.Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence.Am J Surg Pathol. 2009 Oct;33(10):1425-39.
  • Beck AH, Weng Z, Witten DM, Zhu S, Foley JW, Lacroute P, Smith CL, Tibshirani R, van de Rijn M, Sidow A, West RB.3'-end sequencing for expression quantification (3SEQ) from archival tumor samples.PLoS ONE. 2010;5(1):e8768.
  • Subramanian S, Thayanithy V, West RB, Lee CH, Beck AH, Zhu S, Downs-Kelly E, Montgomery K, Goldblum JR, Hogendoorn PC, Corless CL, Oliveira AM, Dry SM, Nielsen TO, Rubin BP, Fletcher JA, Fletcher CD, van de Rijn M.Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours.J Pathol. 2010 Jan;220(1):58-70.
  • Lee CH, Subramanian S, Beck AH, Espinosa I, Senz J, Zhu SX, Huntsman D, van de Rijn M, Gilks CB.MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary.PLoS ONE. 2009;4(10):e7314.
  • Natkunam Y, Tedoldi S, Paterson JC, Zhao S, Rodriguez-Justo M, Beck AH, Siebert R, Mason DY, Marafioti T.Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia.Am J Clin Pathol. 2009 Sep;132(3):361-71.
  • Espinosa I, Beck AH, Lee CH, Zhu S, Montgomery KD, Marinelli RJ, Ganjoo KN, Nielsen TO, Gilks CB, West RB, van de Rijn M.Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma.Am J Pathol. 2009 Jun;174(6):2347-56.
  • Sangoi AR, Dulai MS, Beck AH, Brat DJ, Vogel H.Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.Am J Surg Pathol. 2009 May;33(5):669-81.
  • Weinberg OK, Ma L, Seo K, Beck AH, Pai RK, Morales A, Kim Y, Sundram U, Tan D, Horning SJ, Hoppe RT, Natkunam Y, Arber DA.Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin.Am J Surg Pathol. 2009 Apr;33(4):591-8.
  • Beck AH, Espinosa I, Edris B, Li R, Montgomery K, Zhu S, Varma S, Marinelli RJ, van de Rijn M, West RB.The macrophage colony-stimulating factor 1 response signature in breast carcinoma.Clin Cancer Res. 2009 Feb 1;15(3):778-87.
  • Beck AH, Espinosa I, Gilks CB, van de Rijn M, West RB.The fibromatosis signature defines a robust stromal response in breast carcinoma.Lab Invest. 2008 Jun;88(6):591-601.
  • Sabo E, Beck AH, Montgomery EA, Bhattacharya B, Meitner P, Wang JY, Resnick MB.Computerized morphometry as an aid in determining the grade of dysplasia and progression to adenocarcinoma in Barrett's esophagus.Lab Invest. 2006 Dec;86(12):1261-71.
  • Beck AH.STUDENTJAMA. The Flexner report and the standardization of American medical education.JAMA. 2004 May 5;291(17):2139-40.